Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Jul 9;17(7):e87632.
doi: 10.7759/cureus.87632. eCollection 2025 Jul.

Local Anesthetics in Diabetic Retinopathy Procedures: A Comprehensive Review With a Focus on Lidocaine-Based Pain Control

Affiliations
Review

Local Anesthetics in Diabetic Retinopathy Procedures: A Comprehensive Review With a Focus on Lidocaine-Based Pain Control

Kimia Rezaei et al. Cureus. .

Abstract

This review investigates commonly used local anesthetic agents and administration methods in diabetic retinopathy (DR) procedures, such as pan-retinal photocoagulation, intravitreal injections, and vitrectomy, focusing on pain control and procedural outcomes. A systematic review of PubMed was conducted to identify studies examining local anesthetic use in DR procedures. Studies were screened for relevance, full-text availability, and methodological rigor. Fourteen studies met the inclusion criteria and were evaluated for anesthetic type, dosage, application route, co-administration, and patient outcome. The Joanna Briggs Institute (JBI) critical appraisal tools were used to evaluate the methodological quality and risk of bias for each included study. Lidocaine emerged as the most frequently used anesthetic, effectively reducing pain and systolic pressure during pan-retinal photocoagulation and posterior vitrectomy. There was a statistically significant difference in the dosage of lidocaine (2.33 ± 1.00%) vs other alternative anesthetics (0.475 ± 0.05%) for surgical procedures used to treat DR. The topical application of lidocaine was preferred for its ease of administration and reduced risk of complications. Furthermore, povidone, an antiseptic agent, was frequently co-administered to disinfect the ocular surface and maintain aseptic conditions during intravitreal injections, reducing the risk of infection. Among the local anesthetics reviewed, lidocaine, administered topically or via injection, was most frequently studied and demonstrated effective procedural analgesia and favorable post-surgical outcomes. These findings suggest lidocaine is a suitable choice for DR procedures. Exploration of lidocaine's impact, consideration of patient medical history, and examination of a broader range of co-administered drugs are recommended for comprehensive insights into optimizing patient outcomes.

Keywords: anesthesia; diabetic retinopathy; lidocaine; pain management; panretinal photocoagulation; surgical outcomes.

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.

Figures

Figure 1
Figure 1. PRISMA flow diagram illustrating the selection of studies for the review on anesthesia use in diabetic retinopathy surgery.
PRISMA: Preferred Reporting Items for Systematic Reviews and Meta-Analyses

Similar articles

References

    1. Prevalence of diabetic retinopathy in the US in 2021. Lundeen EA, Burke-Conte Z, Rein DB, Wittenborn JS, Saaddine J, Lee AY, Flaxman AD. JAMA Ophthalmol. 2023;141:747–754. - PMC - PubMed
    1. Of neurons and pericytes: the neuro-vascular approach to diabetic retinopathy. Eleftheriou CG, Ivanova E, Sagdullaev BT. Vis Neurosci. 2020;37:0. - PubMed
    1. Retinal cell damage in diabetic retinopathy. Zhou J, Chen B. Cells. 2023;12:1342. - PMC - PubMed
    1. The microenvironment of proliferative diabetic retinopathy supports lymphatic neovascularization. Gucciardo E, Loukovaara S, Korhonen A, et al. J Pathol. 2018;245:172–185. - PubMed
    1. Diabetic retinopathy. Shaya FT, Aljawadi M. https://pmc.ncbi.nlm.nih.gov/articles/PMC2701130/ Clin Ophthalmol. 2007;1:259–265. - PMC - PubMed

LinkOut - more resources